Show simple item record

dc.contributor.authorSariola, S
dc.contributor.authorButcher, A
dc.contributor.authorCañada, JA
dc.contributor.authorAïkpé, M
dc.contributor.authorCompaore, A
dc.date.accessioned2022-09-01T08:27:23Z
dc.date.issued2022-07-27
dc.date.updated2022-08-31T15:50:46Z
dc.description.abstractAntimicrobial resistance (AMR) is a global concern that is geographically unevenly distributed, with low- and middle-income countries and African countries suffering in particular. The World Health Organization (WHO) Global Action Plan (GAP) for antimicrobial resistance identified five key objectives that aim to ensure the continued treatment and prevention of infectious diseases with the use of antibiotics. Countries signatory to the WHO GAP are expected to develop their own national action plans (NAPs) based on the global model. How low-income countries are able to achieve the GAP objectives is not well understood. This paper analyzes the progress of two West African countries in achieving the GAP targets, Benin and Burkina Faso, countries among the lowest bracket in the World Development Index. We present qualitative data from interviews and focus group discussions with local policy-makers, nurses, doctors, animal breeders, veterinarians, and laboratory researchers, supported by participant observations and surveys within rural communities. The analysis is organized according to the five WHO GAP objectives to show the countries' challenges in fulfilling them. The analysis shows that there are shortcomings in all of the WHO GAP areas in the two countries, making it a compounded and multifactorial problem-a stacking of lacks. In such contexts, calibrating a society toward AMR resilience/prevention requires overall development and attention to interdependencies. Active local research and policy communities with international, sustained financial support are essential for achieving the targets. IMPORTANCE The burden of antimicrobial resistance (AMR) is unequally distributed across the globe. Low-income countries face a more severe AMR situation and have fewer means to solve the problem. This paper brings out the voices of local experts, policy-makers, and members of the community in Benin and Burkina Faso across human health, animal health, and food production sectors, where the majority of antibiotic use is concentrated. We describe the difficulties that they face in implementing global action plans, targets set by the World Health Organization, for securing antibiotics and preventing the spread of antimicrobial resistance. This paper argues that the various deficits in implementation are stacked, multisectoral, and compounded. We highlight the role of active local scientists and policy-maker networks in setting priorities to address the AMR problem; however, their activities need technical and financial support from international partners.en_GB
dc.description.sponsorshipAcademy of Finlanden_GB
dc.description.sponsorshipMinistry of Foreign Affairs, Finlanden_GB
dc.format.extente0015022-
dc.format.mediumPrint-Electronic
dc.identifier.citationVol. 7(4), article e0015022en_GB
dc.identifier.doihttps://doi.org/10.1128/msystems.00150-22
dc.identifier.grantnumber318730en_GB
dc.identifier.grantnumber324322en_GB
dc.identifier.urihttp://hdl.handle.net/10871/130628
dc.language.isoenen_GB
dc.publisherAmerican Society for Microbiologyen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/35894597en_GB
dc.rights© 2022 Sariola et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license.en_GB
dc.subjectBeninen_GB
dc.subjectBurkina Fasoen_GB
dc.subjectWest Africaen_GB
dc.subjectantimicrobial resistanceen_GB
dc.subjectinequalityen_GB
dc.subjectlow-income countriesen_GB
dc.subjectqualitative researchen_GB
dc.titleClosing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Fasoen_GB
dc.typeArticleen_GB
dc.date.available2022-09-01T08:27:23Z
dc.identifier.issn2379-5077
exeter.place-of-publicationUnited States
dc.descriptionThis is the final version. Available on open access from the American Society for Microbiology via the DOI in this recorden_GB
dc.identifier.eissn2379-5077
dc.identifier.journalmSystemsen_GB
dc.relation.ispartofmSystems, 7(4)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-07-11
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-07-27
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-09-01T08:20:39Z
refterms.versionFCDVoR
refterms.dateFOA2022-09-01T08:27:31Z
refterms.panelCen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2022 Sariola et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Except where otherwise noted, this item's licence is described as © 2022 Sariola et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license.